Sg Americas Securities, LLC Astrazeneca PLC Transaction History

Sg Americas Securities, LLC

$30.5 Billion
Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sg Americas Securities, LLC holds 4,616 shares of AZN stock, worth $311,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,616

Previous 213,587 97.84%

Holding current value

$311,995

Previous $14 Million 97.58%

% of portfolio

0.0%

Previous 0.06%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$65.37 - $77.96 $13.7 Million - $16.3 Million	-208,971 Reduced 97.84%	4,616 $339,000
Q4 2024 Jan 17, 2025	BUY	$63.2 - $79.58 $12.4 Million - $15.7 Million	196,772 Added 1170.22%	213,587 $14 Million
Q3 2024 Oct 03, 2024	SELL	$76.67 - $87.62 $1.25 Million - $1.43 Million	-16,357 Reduced 49.31%	16,815 $1.31 Million
Q2 2024 Jul 12, 2024	BUY	$66.81 - $80.83 $471,411 - $570,336	7,056 Added 27.02%	33,172 $2.59 Million
Q1 2024 May 06, 2024	SELL	$61.03 - $69.57 $817,374 - $931,751	-13,393 Reduced 33.9%	26,116 $1.77 Million
Q4 2023 Jan 12, 2024	SELL	$61.89 - $69.28 $3.57 Million - $4 Million	-57,701 Reduced 59.36%	39,509 $2.66 Million
Q3 2023 Oct 13, 2023	SELL	$64.85 - $71.7 $666,528 - $736,932	-10,278 Reduced 9.56%	97,210 $6.58 Million
Q2 2023 Jul 10, 2023	SELL	$69.91 - $75.81 $3.2 Million - $3.47 Million	-45,837 Reduced 29.9%	107,488 $7.69 Million
Q1 2023 Apr 28, 2023	BUY	$63.15 - $71.6 $6.46 Million - $7.32 Million	102,286 Added 200.41%	153,325 $10.6 Million
Q4 2022 Feb 02, 2023	SELL	$54.21 - $70.44 $126,309 - $164,125	-2,330 Reduced 4.37%	51,039 $3.46 Million
Q3 2022 Oct 31, 2022	BUY	$53.02 - $135.75 $567,473 - $1.45 Million	10,703 Added 25.09%	53,369 $2.93 Million
Q2 2022 Jul 29, 2022	SELL	$59.26 - $71.14 $81,660 - $98,030	-1,378 Reduced 3.13%	42,666 $2.82 Million
Q1 2022 Apr 29, 2022	BUY	$55.72 - $67.12 $611,359 - $736,440	10,972 Added 33.18%	44,044 $2.92 Million
Q4 2021 Feb 07, 2022	SELL	$54.02 - $63.83 $213,973 - $252,830	-3,961 Reduced 10.7%	33,072 $1.93 Million
Q3 2021 Nov 01, 2021	SELL	$55.56 - $60.79 $1.43 Million - $1.56 Million	-25,668 Reduced 40.94%	37,033 $2.22 Million
Q2 2021 Aug 12, 2021	SELL	$48.42 - $60.18 $485,894 - $603,906	-10,035 Reduced 13.8%	62,701 $3.76 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $2.82 Million - $3.25 Million	59,767 Added 460.85%	72,736 $3.62 Million
Q4 2020 Feb 04, 2021	BUY	$48.52 - $58.02 $250,848 - $299,963	5,170 Added 66.29%	12,969 $648,000
Q3 2020 Nov 09, 2020	BUY	$53.07 - $61.1 $218,754 - $251,854	4,122 Added 112.1%	7,799 $427,000
Q2 2020 Jul 20, 2020	SELL	$43.1 - $55.31 $344,972 - $442,701	-8,004 Reduced 68.52%	3,677 $194,000
Q1 2020 Apr 30, 2020	BUY	$37.79 - $51.33 $441,424 - $599,585	11,681 New	11,681 $522,000
Q4 2019 Jan 28, 2020	SELL	$42.46 - $50.46 $5.75 Million - $6.83 Million	-135,398 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$40.12 - $45.47 $388,602 - $440,422	9,686 Added 7.7%	135,398 $6.04 Million
Q2 2019 Jul 29, 2019	BUY	$37.28 - $41.68 $4.69 Million - $5.24 Million	125,712 New	125,712 $5.19 Million
Q1 2019 Apr 29, 2019	SELL	$35.49 - $43.02 $4.31 Million - $5.23 Million	-121,559 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$36.86 - $41.49 $4.48 Million - $5.04 Million	121,559 New	121,559 $4.62 Million
Q3 2018 Nov 06, 2018	SELL	$34.76 - $39.72 $5.03 Million - $5.75 Million	-144,839 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$34.55 - $37.05 $3.97 Million - $4.26 Million	114,917 Added 384.06%	144,839 $5.09 Million
Q1 2018 May 03, 2018	BUY	$32.97 - $36.63 $986,528 - $1.1 Million	29,922 New	29,922 $1.05 Million
Q4 2017 Jan 24, 2018	SELL	$32.09 - $34.78 $574,699 - $622,875	-17,909 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $518,644 - $608,906	17,909	17,909 $607,000

Others Institutions Holding AZN

# of Institutions

1,378

Shares Held

476M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $209B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Astrazeneca PLC Transaction History